Bladex (US.BLX)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.BLX · YoY: 2026 H1 vs 2025 H1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | - | → |
| ROE | 7.0% | ↓ |
| Cash Conversion | 0.0% | ↓ |
| D/E Ratio | 2.37 | ↑ |
| Gross Margin | 0.0% | ↓ |
US.BLX (Bladex) | YoY: 2026 H1 vs 2025 H1 Metric Value YoY --------------------------- FCF Conversion - → ROE 7.0% ↓ Cash Conversion 0.0% ↓ D/E Ratio 2.37 ↑ Gross Margin 0.0% ↓
Key Metrics
US.BLX (Bladex) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY---------------------------FCF Conversion - →ROE 7.0% ↓Cash Conversion 0.0% ↓D/E Ratio 2.37 ↑Gross Margin 0.0% ↓Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies